Clearmind Medicine (CMND) vs Onconetix (ONCO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Onconetix is the larger company by market cap ($3.4 million vs $3.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | CMND | ONCO |
|---|---|---|
| Share price | $6.60 | $0.6543 |
| Market cap | $3.35M | $3.43M |
| 1-day change | 0.00% | +9.56% |
| P/E ratio (TTM) | — | 0.00 |
| EPS (TTM) | $-461.20 | $310.39 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3,840.00 | $209.50 |
| 52-week low | $5.25 | $0.58 |
| Distance from 52-week high | -99.83% | -99.69% |
| Average volume | 70.35K | 2.23M |
| Shares outstanding | 507.40K | 5.24M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
CMND vs ONCO FAQ
Which is bigger, Clearmind Medicine or Onconetix?
Onconetix (ONCO) is larger, with a market capitalization of $3.43M compared with $3.35M for Clearmind Medicine (CMND).
Are Clearmind Medicine and Onconetix in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.